ID

34480

Beskrivning

Periperal Blood Lymphocytes During Prostate RT; ODM derived from: https://clinicaltrials.gov/show/NCT01899391

Länk

https://clinicaltrials.gov/show/NCT01899391

Nyckelord

  1. 2019-01-17 2019-01-17 -
  2. 2019-05-22 2019-05-22 -
Rättsinnehavare

see on clinicaltrials.gov

Uppladdad den

17 januari 2019

DOI

För en begäran logga in.

Licens

Creative Commons BY-NC 3.0

Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Prostate Cancer NCT01899391

Eligibility Prostate Cancer NCT01899391

Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
intermediate-risk prostate cancer patients (t1/t2n0m0 with either gs < 7 and psa between 10-20 ng/ml or gs 7 and psa less than 20 ng/ml).
Beskrivning

ID.1

Datatyp

boolean

planned for radical rt to the prostate with imrt planning (79gy/39fractions or 60 gy/20 fractions).
Beskrivning

ID.2

Datatyp

boolean

no contraindications to diagnostic ct scanning.
Beskrivning

ID.3

Datatyp

boolean

prostate volumes will be less than 80 cc to control the planning dose volume histogram (dvh) as much as possible in terms of rectal and bladder volumes.
Beskrivning

ID.4

Datatyp

boolean

no known dna repair disorders (e.g. family history of at, brca1/2 or li fraumeni syndrome) or contraindications to radical pelvic rt.
Beskrivning

ID.5

Datatyp

boolean

Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
inability to provide informed consent.
Beskrivning

ID.6

Datatyp

boolean

patient having contraindications to diagnostic ct scan.
Beskrivning

ID.7

Datatyp

boolean

patients who have unobtainable data regarding previous therapy and their clinical outcome.
Beskrivning

ID.8

Datatyp

boolean

patients should not have any diagnostic x-rays or cat scans 2 weeks prior to their enrollment into the study.
Beskrivning

ID.9

Datatyp

boolean

Similar models

Eligibility Prostate Cancer NCT01899391

Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
intermediate-risk prostate cancer patients (t1/t2n0m0 with either gs < 7 and psa between 10-20 ng/ml or gs 7 and psa less than 20 ng/ml).
boolean
ID.2
Item
planned for radical rt to the prostate with imrt planning (79gy/39fractions or 60 gy/20 fractions).
boolean
ID.3
Item
no contraindications to diagnostic ct scanning.
boolean
ID.4
Item
prostate volumes will be less than 80 cc to control the planning dose volume histogram (dvh) as much as possible in terms of rectal and bladder volumes.
boolean
ID.5
Item
no known dna repair disorders (e.g. family history of at, brca1/2 or li fraumeni syndrome) or contraindications to radical pelvic rt.
boolean
Item Group
C0680251 (UMLS CUI)
ID.6
Item
inability to provide informed consent.
boolean
ID.7
Item
patient having contraindications to diagnostic ct scan.
boolean
ID.8
Item
patients who have unobtainable data regarding previous therapy and their clinical outcome.
boolean
ID.9
Item
patients should not have any diagnostic x-rays or cat scans 2 weeks prior to their enrollment into the study.
boolean

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial